AbbVie

Zebra Biologics Inc., a Concord-based emerging pre-clinical biotechnology company, is collaborating with Worcester global biopharma AbbVie to discover agonist antibody therapies for inflammatory diseases.

Local manufacturers lay out the steps it takes to find success in the international market.

Many of the top 100 employers in Central Massachusetts are from the state's biotech industry.

AbbVie, the North Chicago, Ill.-based biopharma with a research center in Worcester, has received a challenge to one of its patents for Humira.

Central Massachusetts companies from Worcester to Milford and over to Framingham have pledged to grow their businesses by more than 120 jobs in exchange for $1.845 million in tax incentives from the Massachusetts Life Sciences Center (MLSC).

Worcester pharmaceutical firm AbbVie has received priority review status from the U.S. Food & Drug Administration for its drug meant to treat those suffering from chronic hepatitis C virus.

With its hybrid of open spaces and an educated workforce, Central Massachusetts is set to reap the rewards as the state's biomanufacturing initiative kicks into its second phase.

Pharmaceuticals giant AbbVie, which has operations in Worcester, has completed its purchase of California-based Pharmacyclics Inc., AbbVie announced Tuesday.

Pharmaceutical giant AbbVie, which has operations in Worcester, is extending by another week its offer for all outstanding shares of Pharmacyclics to Friday afternoon.

Pharmaceutical giant AbbVie, which has operations in Worcester, has extended its offer to buy California-based Pharmacyclics to May 15, the company announced.